During the past decade, Ospedale San Carlo conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Carlo" #1 sponsor was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 6 trials, followed by "Amgen" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "National Cancer Institute, Naples" with 4 trials sponsored and "Università Vita-Salute San Raffaele" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Carlo" #1 collaborator was "Azienda Policlinico Umberto I" with 2 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Regione Lombardia" with 2 trials as a collaborator and "Acute Leukemia French Association" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Carlo" are "Leukemia" (4 trials), "Advanced Colorectal Cancer" (2 trials), "Hematologic Diseases" (2 trials), "Lung Cancer" (2 trials) and "Stem Cell Transplant Complications" (2 trials). Many other conditions were trialed in "Ospedale San Carlo" in a lesser frequency.

Most popular intervention types in "Ospedale San Carlo" are "Drug" (37 trials), "Procedure" (9 trials), "Other" (6 trials), "Radiation" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "allogeneic bone marrow transplantation" (3 trials), "autologous bone marrow transplantation" (3 trials), "cyclophosphamide" (3 trials) and "cytarabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Carlo" are 49 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Carlo". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Ospedale San Carlo, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Carlo, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".

Ospedale San Carlo has several departments that took part in Clinical trials: "Ospedale S. Giovanni Di Dio - U.O. Cardiologia E Utic" - 3 trials, "Ospedale San Carlo; Day Hospital Oncologia Medica" - 3 trials, "Azienda Ospedaliera San Carlo - Ssd Utic" - 3 trials